Search

everythinglearnresearchcommunity

for

Search:↓

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Overweight smokers have worse hair loss.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Both genetic and lifestyle factors significantly affect female hair loss.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.